The National Taiwan University Hospital is a medical facility located in the Zhongzheng District of Taipei, Taiwan. It started operations under Japanese rule in Daitōtei on 18 June 1895, and moved to its present location in 1898.

There are 2,400 beds in National Taiwan Uni Hospital; General Surgery.

During the past decade, National Taiwan Uni Hospital; General Surgery conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Taiwan Uni Hospital; General Surgery" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Actelion" with 3 trials sponsored, "Bio-medical Carbon Technology Co., Ltd." with 2 trials sponsored, "National Taiwan University Hospital" with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Taiwan Uni Hospital; General Surgery" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "National Science Council, Taiwan" with 2 trials as a collaborator, "National Taiwan University Hospital" with 2 trials as a collaborator and "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "National Taiwan Uni Hospital; General Surgery" are "Breast Cancer" (7 trials), "Pulmonary Arterial Hypertension" (3 trials), "Burns" (2 trials), "Triple-Negative Breast Cancer" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "National Taiwan Uni Hospital; General Surgery" in a lesser frequency.

Most popular intervention types in "National Taiwan Uni Hospital; General Surgery" are "Drug" (18 trials), "Procedure" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.

The vast majority of trials in "National Taiwan Uni Hospital; General Surgery" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Taiwan Uni Hospital; General Surgery". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in National Taiwan Uni Hospital; General Surgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Taiwan Uni Hospital; General Surgery, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".